Putri, D. A., Setiawan, D. and Yamsun, M. (2025) “Cost-Utility Analysis Addition of Bevacizumab to Standard Chemotherapy in KRAS-mutation Colorectal Cancer”, PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia), 22(1), pp. 6–11. doi: 10.30595/pharmacy.v22i1.24298.